LQDA Overview
Upcoming Projects (LQDA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (LQDA)
-
A look at the use of Treprostinil in PAH and the potential of Liquidia's Yutrepia DPI in the market
Tickers: LQDA, UTHR
Executed On: Aug 10, 2022 at 02:00 PM EDT -
Untangling the LQDA / UTHR IP and Legal Landscape and the implications on YUTREPIA & Tyvaso
Tickers: LQDA, UTHR
Executed On: Jul 28, 2022 at 12:00 PM EDT
Expired Projects (LQDA)
-
Advancing Pulmonary Hypertension Treatment: A Deep Dive into Liquidia's Clinical Trials Results for L606 and YUTREPIA PDUFA Jan 24
Ticker: LQDA
Execute By: Feb 29, 2024
Upcoming & Overdue Catalysts (LQDA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (LQDA)
-
Liquidia's (LQDA) LIQ861 in Pulmonary arterial hypertension PDUFA date due November 7, 2021
Ticker: LQDA
Occurred on: Nov 08, 2021
Strategic Initiatives (LQDA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
